
Cencora, Inc.
Cencora, Inc. is a United States-based company in the Healthcare sector with a market capitalisation of $65.1B. Its FinScore is 65/100; its highest-scoring layer is Momentum (79) and its lowest is Growth (40). The shares trade at 24.8x trailing earnings and are up 1% year to date.
Share price performance
About Cencora, Inc.
www.cencora.comCencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- HQ
- United States
- Fiscal year-end
- September
- Trading currency
- USD
- Reporting currency
- USD
- Fundamentals updated
- 74 days ago
- Market cap
- $65.1B
- Shares outstanding
- 190.8M
- P/E (TTM)
- 24.8x
- Dividend yield (TTM)
- 0.70%
- Beta (issuer)
- 0.58
- Revenue (latest FY)
- $321.3B
Revenue breakdown
- Pharmaceutical Distribution88.8%$285.3B
- International Healthcare Solutions9.4%$30.4B
- Animal Health1.8%$5.7B
FinScore
As of 2026-10-19Snapshot
Ownership
As of 2026-06-30Sign up or log in to see Analysis
Analysis for Cencora, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Financials
Financials for Cencora, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Estimates
Estimates for Cencora, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Peers
Peers for Cencora, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Valuation
Valuation for Cencora, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see News
News for Cencora, Inc. is available to Finryse members. The Overview stays open to everyone; creating an account is free.